Work

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-014-2947-1

Authors: Masashi Ando, Hideko Yamauchi, Kenjiro Aogi, Satoru Shimizu, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Kenichi Inoue, Shinji Ohono, Katsumasa Kuroi, Tetsutaro Hamano, Tamie Sukigara, Yasuhiro Fujiwara

Institutions: Aichi Cancer Center, Aichi Cancer Center Hospital, St. Luke's International Hospital, Shikoku Cancer Center, Kanagawa Cancer Center, Osaka National Hospital, Chiba Cancer Center, Saitama Cancer Center, National Hospital Organization Kyushu Cancer Center, Tokyo Metropolitan Komagome Hospital, Kitasato University, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Kyowa Hakko Kirin, Eli Lilly Japan

OpenAlex ID: W2010208073

FWCI: 2.175

Cites: 25

Cited by: 79

Related to: 10